OpenURL Connection Search

Select item for more details and to access through your institution.

Cytochrome P450 Epoxygenase Dependence of Opioid Analgesia: Fluconazole Does Not Interfere With Remifentanil-Mediated Analgesia in Human Subjects.
Published in:
Clinical Pharmacology & Therapeutics, 2014, v. 96, n. 6, p. 684, doi. 10.1038/clpt.2014.169
By:
- Oertel, B G;
- Vermehren, J;
- Huynh, T T;
- Doehring, A;
- Ferreiros, N;
- Zimmermann, M;
- Geisslinger, G;
- Lötsch, J
Publication type:
Article
CONTRAST ENHANCED ULTRASOUND (CEUS) HAS A HIGH DIAGNOSTIC VALUE IN CHILDREN WITH FOCAL LIVER LESIONS (FLL)
Published in:
Journal of Pediatric Gastroenterology & Nutrition, 2006, v. 42, n. 5, p. E77, doi. 10.1002/j.1536-4801.2006.tb01848.x
By:
- Grothues, D;
- Knoppke, B;
- Pfister, ED;
- Vermehren, J;
- Rauschenfels, S;
- Gebel, M;
- Melter, M
Publication type:
Article
CAUSES OF NON‐ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN INFANTS AND CHILDREN.
Published in:
Journal of Pediatric Gastroenterology & Nutrition, 2006, v. 42, n. 5, p. E61, doi. 10.1002/j.1536-4801.2006.tb01742.x
By:
- Knoppke, B;
- Pfister, ED;
- Grothues, D;
- Vermehren, J;
- Rauschenfels, S;
- Melter, M
Publication type:
Article
Regression of fibrosis and portal hypertension in HCV-associated cirrhosis and sustained virologic response after interferon-free antiviral therapy.
Published in:
Journal of Viral Hepatitis, 2016, v. 23, n. 12, p. 994, doi. 10.1111/jvh.12578
By:
- Knop, V.;
- Hoppe, D.;
- Welzel, T.;
- Vermehren, J.;
- Herrmann, E.;
- Vermehren, A.;
- Friedrich‐Rust, M.;
- Sarrazin, C.;
- Zeuzem, S.;
- Welker, M.‐W.
Publication type:
Article
Letter: adoption of uniform nomenclature is crucial for estimating the true risk of HBV reactivation in patients treated with direct‐acting antivirals for hepatitis C.
Published in:
2018
By:
- Mücke, M. M.;
- Mücke, V. T.;
- Vermehren, J.
Publication type:
Letter to the Editor
Editorial: genotype 3 HCV—who still needs ribavirin in a pan‐genotypic era? Authors’ reply.
Published in:
2018
By:
- von Felden, J.;
- Vermehren, J.;
- Schulze zur Wiesch, J.;
- Sarrazin, C.;
- Christensen, S.
Publication type:
Editorial
Impact of HBV genotype and mutations on HBV DNA and qHBsAg levels in patients with HBeAg‐negative chronic HBV infection.
Published in:
Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 11, p. 1523, doi. 10.1111/apt.14636
By:
- Kuhnhenn, L.;
- Jiang, B.;
- Kubesch, A.;
- Vermehren, J.;
- Knop, V.;
- Susser, S.;
- Dietz, J.;
- Carra, G.;
- Finkelmeier, F.;
- Grammatikos, G.;
- Zeuzem, S.;
- Sarrazin, C.;
- Hildt, E.;
- Peiffer, K.‐H.
Publication type:
Article
High efficacy of sofosbuvir/velpatasvir and impact of baseline resistance‐associated substitutions in hepatitis C genotype 3 infection.
Published in:
Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 9, p. 1288, doi. 10.1111/apt.14592
By:
- von Felden, J.;
- Vermehren, J.;
- Ingiliz, P.;
- Mauss, S.;
- Lutz, T.;
- Simon, K. G.;
- Busch, H. W.;
- Baumgarten, A.;
- Schewe, K.;
- Hueppe, D.;
- Boesecke, C.;
- Rockstroh, J. K.;
- Daeumer, M.;
- Luebke, N.;
- Timm, J.;
- Schulze zur Wiesch, J.;
- Sarrazin, C.;
- Christensen, S.
Publication type:
Article
Letter: low rates of HBV serology testing in patients with chronic hepatitis C receiving direct acting antivirals - Authors' reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 9, p. 909, doi. 10.1111/apt.14286
By:
- Mücke, M. M.;
- Mücke, V. T.;
- Vermehren, J.
Publication type:
Article
Letter: the potential risk of HBV reactivation in patients with resolved HBV infection during direct-acting antiviral therapy - authors' reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 7, p. 703, doi. 10.1111/apt.14259
By:
- Mücke, M. M.;
- Mücke, V. T.;
- Vermehren, J.
Publication type:
Article
No evidence of hepatitis B virus reactivation in patients with resolved infection treated with direct-acting antivirals for hepatitis C in a large real-world cohort.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 4, p. 432, doi. 10.1111/apt.14177
By:
- Mücke, V. T.;
- Mücke, M. M.;
- Peiffer, K.‐H.;
- Weiler, N.;
- Welzel, T. M.;
- Sarrazin, C.;
- Zeuzem, S.;
- Berger, A.;
- Vermehren, J.
Publication type:
Article
The efficacy and safety of direct acting antiviral treatment and clinical significance of drug-drug interactions in elderly patients with chronic hepatitis C virus infection.
Published in:
Alimentary Pharmacology & Therapeutics, 2016, v. 44, n. 8, p. 856, doi. 10.1111/apt.13769
By:
- Vermehren, J.;
- Peiffer, K.‐H.;
- Welsch, C.;
- Grammatikos, G.;
- Welker, M.‐W.;
- Weiler, N.;
- Zeuzem, S.;
- Welzel, T. M.;
- Sarrazin, C.
Publication type:
Article
Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus.
Published in:
Journal of Viral Hepatitis, 2015, v. 22, n. 4, p. 427, doi. 10.1111/jvh.12309
By:
- Dultz, G.;
- Gerber, L.;
- Farnik, H.;
- Berger, A.;
- Vermehren, J.;
- Pleli, T.;
- Zeuzem, S.;
- Piiper, A.;
- Kronenberger, B.;
- Waidmann, O.
Publication type:
Article
Mutations selected in the hepatitis C virus NS3 protease domain during sequential treatment with boceprevir with and without pegylated interferon alfa-2b.
Published in:
Journal of Viral Hepatitis, 2012, v. 19, n. 2, p. 120, doi. 10.1111/j.1365-2893.2011.01449.x
By:
- Vermehren, J.;
- Susser, S.;
- Lange, C. M.;
- Forestier, N.;
- Karey, U.;
- Hughes, E.;
- Ralston, R.;
- Tong, X.;
- Zeuzem, S.;
- Sarrazin, C.
Publication type:
Article

Found: 14